258 related articles for article (PubMed ID: 33781531)
21. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ
Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052
[TBL] [Abstract][Full Text] [Related]
22. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation.
Nozzoli C; Bartolozzi B; Guidi S; Orsi A; Vannucchi AM; Leoni F; Bosi A
Leuk Lymphoma; 2006 Jan; 47(1):167-9. PubMed ID: 16321845
[TBL] [Abstract][Full Text] [Related]
24. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.
Gibson SE; Picarsic J; Swerdlow SH; Pantanowitz L
Cancer Cytopathol; 2016 Jun; 124(6):425-35. PubMed ID: 26992116
[TBL] [Abstract][Full Text] [Related]
25. Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell Transplantation.
Marzolini MAV; Wilson AJ; Sanchez E; Carpenter B; Chakraverty R; Hough R; Kottaridis P; Morris EC; Thomson KJ; Peggs KS
Transplant Cell Ther; 2021 Aug; 27(8):682.e1-682.e12. PubMed ID: 33962069
[TBL] [Abstract][Full Text] [Related]
26. Noninfectious Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation.
Balaguer-Rosello A; Bataller L; Piñana JL; Montoro J; Lorenzo I; Villalba A; Freiria C; Santiago M; Sevilla T; Muelas N; Guerreiro M; Carretero C; Gómez I; Solves P; Sanz MÁ; Sanz G; Sanz J
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1818-1824. PubMed ID: 31132454
[TBL] [Abstract][Full Text] [Related]
27. Features of Epstein-Barr virus reactivation after allogeneic hematopoietic cell transplantation in Korean children living in an area of high seroprevalence against Epstein-Barr virus.
Han SB; Bae EY; Lee JW; Jang PS; Lee DG; Chung NG; Jeong DC; Cho B; Lee SJ; Kang JH; Kim HK
Int J Hematol; 2014 Aug; 100(2):188-99. PubMed ID: 24981711
[TBL] [Abstract][Full Text] [Related]
28. Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives.
Compagno F; Basso S; Panigari A; Bagnarino J; Stoppini L; Maiello A; Mina T; Zelini P; Perotti C; Baldanti F; Zecca M; Comoli P
Front Immunol; 2020; 11():567020. PubMed ID: 33042147
[TBL] [Abstract][Full Text] [Related]
29. Intrathecal therapy with rituximab in central nervous system involvement of post-transplant lymphoproliferative disorder.
Czyzewski K; Styczynski J; Krenska A; Debski R; Zajac-Spychala O; Wachowiak J; Wysocki M
Leuk Lymphoma; 2013 Mar; 54(3):503-6. PubMed ID: 22873830
[TBL] [Abstract][Full Text] [Related]
30. Distinctive Clinicopathologic Features of Monomorphic B-cell Post-transplant Lymphoproliferative Disorders in Children.
Zhang Y; Mariani R; Gong M; Kirschmann D; Caparelli E; Wallace N; Turner R; Lu X; Gao J; Yap KL; Gong S
Pediatr Dev Pathol; 2021; 24(4):318-326. PubMed ID: 33872109
[TBL] [Abstract][Full Text] [Related]
31. Non-uniform
Burns DM; Ryan GB; Harvey CM; Nagy E; Hughes S; Murray PG; Russell NH; Fox CP; Long HM
Front Immunol; 2019; 10():2489. PubMed ID: 31736946
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of Epstein-Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant.
Lindsay J; Othman J; Yong MK; Ritchie D; Chee L; Tay K; Tio SY; Kerridge I; Fay K; Stevenson W; Arthur C; Chen SC; Kong DCM; Greenwood M; Pergam SA; Liu C; Slavin MA
Transpl Infect Dis; 2021 Oct; 23(5):e13719. PubMed ID: 34453768
[TBL] [Abstract][Full Text] [Related]
33. Toxoplasmic Encephalitis Followed by Primary EBV-Associated Post-Transplant Lymphoproliferative Disorder of the Central Nervous System in a Patient Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Case Report.
Mayumi A; Yamashita T; Matsuda I; Hikosaka K; Fujino S; Norose K; Kato Y; Hirota S; Nakajima T; Ogawa H; Ikegame K
Transplant Proc; 2020 Nov; 52(9):2858-2860. PubMed ID: 32873410
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes.
Ru Y; Zhang X; Song T; Ding Y; Zhu Z; Fan Y; Xu Y; Sun A; Qiu H; Jin Z; Tang X; Han Y; Fu Z; Chen S; Ma X; Chen F; Chen J; Wu D
Bone Marrow Transplant; 2020 Sep; 55(9):1754-1762. PubMed ID: 32066862
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation.
Liu QF; Fan ZP; Luo XD; Sun J; Zhang Y; Ding YQ
Transpl Infect Dis; 2010 Aug; 12(4):284-91. PubMed ID: 20345506
[TBL] [Abstract][Full Text] [Related]
36. [Clinical risks analysis of EBV infection in patients with allogeneic hematopoietic stem cell transplantation].
Bao X; Zhu Q; Qiu H; Chen F; Xue S; Ma X; Sun A; Wu D
Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):138-43. PubMed ID: 27014984
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?
Nelson BP; Nalesnik MA; Bahler DW; Locker J; Fung JJ; Swerdlow SH
Am J Surg Pathol; 2000 Mar; 24(3):375-85. PubMed ID: 10716151
[TBL] [Abstract][Full Text] [Related]
38. [The efficacy and safety of donor lymphocyte infusion to treat Epstein-Barr virus associated lymphoproliferative diseases after allogeneic hematopoietic stem cell transplantation].
Xu LP; Liu DH; Liu KY; Chen H; Han W; Wang Y; Wang J; Shi HX; Huang XJ
Zhonghua Nei Ke Za Zhi; 2010 Nov; 49(11):955-8. PubMed ID: 21211211
[TBL] [Abstract][Full Text] [Related]
39. Spectrum of Epstein-Barr virus-associated diseases in recipients of allogeneic hematopoietic stem cell transplantation.
Xuan L; Jiang X; Sun J; Zhang Y; Huang F; Fan Z; Guo X; Dai M; Liu C; Yu G; Zhang X; Wu M; Huang X; Liu Q
Transplantation; 2013 Sep; 96(6):560-6. PubMed ID: 23842192
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell Transplantation.
Pagliuca S; Bommier C; Michonneau D; Meignin V; Salmona M; Robin M; Prata PH; Xhaard A; de Fontbrune FS; Feghoul L; Dhedin N; de Latour RP; Caillat-Zucman S; Goff JL; Socié G
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2490-2500. PubMed ID: 31421238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
